Citadel Advisors »

Neuropace shares owned by Citadel Advisors

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $226k 22k 10.31
2025-06-30 $546k 49k 11.14
2025-03-31 $1.5M 125k 12.29
2024-12-31 $452k 40k 11.19
2024-09-30 $125k 18k 6.97
2024-06-30 $346k 46k 7.56
2024-03-31 $273k 21k 13.20
2023-12-31 $248k 24k 10.31
2022-06-30 $109k 22k 5.01
2021-12-31 $101k 10k 10.09
2021-09-30 $411k 26k 15.91